U.S. COMPANY FILING
ABBOTT LABORATORIES — Form 10-Q filed 2025-10-29
Filing text preview
Abbott's Q3 2025 net sales rose 6.9% to $11.37B, with net earnings flat at $1.64B. Nine-month sales increased 6.1% to $32.87B, net earnings up 13.8% to $4.75B. The company initiated restructuring plans and repaid $1.5B in maturing debt.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record